Eastway Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-05-2024
- Paid Up Capital ₹ 0.10 M
as on 21-05-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
About Eastway Pharma
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Madhavan, Jaideep Sundaresh, and Aswathy serve as directors at the Company.
- CIN/LLPIN
U24304KL2020PTC063533
- Company No.
063533
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Eastway Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aswathy  | Managing Director | 10-Aug-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Madhavan | Director | 10-Aug-2020 | Current |
| Jaideep Sundaresh | Director | 10-Aug-2020 | Current |
Financial Performance of Eastway Pharma.
Enhance accessibility to Eastway Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Eastway Pharma?
Unlock access to Eastway Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Elite Bricks And Pavers Private LimitedActive 4 years 6 monthsSunil Madhavan and Jaideep Sundaresh are mutual person
- Magnus Granites Industries Private LimitedActive 4 years 6 months
Sunil Madhavan and Jaideep Sundaresh are mutual person
- Eastway Realtors Private LimitedActive 4 years 6 months
Sunil Madhavan and Jaideep Sundaresh are mutual person
- Kulapara Properties Private LimitedActive 4 years 5 months
Jaideep Sundaresh and Aswathy are mutual person
- Darsan Granites Private LimitedActive 27 years 5 months
Jaideep Sundaresh and Aswathy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eastway Pharma?
Unlock and access historical data on people associated with Eastway Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eastway Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eastway Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
